United States Biotechnology & Medical Research

ImmunoGen Inc (IMGN)

Track

Ticker: IMGN Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for ImmunoGen Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 5 Feb 2024
Value US$2,855,977.07 | Price 393.71 | Shares 76,957 (-10.9%)
Proposed sale 5 Feb 2024
Value US$1,126,510.21 | Price 375.11 | Shares 38,606
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-02-06 2024-02-05 PlS Planned sale
2.5
Enyedy Mark J

CHIEF EXECUTIVE OFFICER

Executive Director
76,957 -10.9%
393.71
US$2,855,977 		76,957 -10.9% 393.71 US$2,855,977
2024-02-06 2024-02-05 PlS Planned sale
1.7
Coen Stacy Ann

SVP & CHIEF BUSINESS OFFICER

Officer
29,835 +41.7%
338.71
US$2,596,294 		29,835 +41.7% 338.71 US$2,596,294
2024-02-06 2024-02-05 PlS Planned sale
1.1
Lentini Renee

VP & PRIN ACCTG OFFICER

Officer
16,514 +5.8%
343.21
US$1,608,195 		16,514 +5.8% 343.21 US$1,608,195
2024-02-06 2024-02-05 PlS Planned sale
1.2
Wingrove Theresa

SVP OF REGULATORY AFFAIRS

Officer
12,027 -36.4%
29.30
US$352,391 		12,027 -36.4% 29.30 US$352,391
2024-02-05 2024-02-05 PrS Proposed sale
1.2
Wingrove Theresa

Officer

Officer
12,027
29.30
US$352,445 		12,027 29.30 US$352,445
2024-02-05 2024-02-05 PrS Proposed sale
1.1
Lentini Renee

Officer

Officer
2,631
29.30
US$77,075 		2,631 29.30 US$77,075
2024-02-05 2024-02-05 PrS Proposed sale
2.5
Enyedy Mark J

Officer; Director

Executive Director
20,107
29.28
US$588,774 		20,107 29.28 US$588,774
2024-02-05 2024-02-05 PrS Proposed sale
1.7
Coen Stacy Ann

Officer

Officer
4,583
29.30
US$134,261 		4,583 29.30 US$134,261
2024-01-18 2024-01-16 PlS Planned sale
1.2
Wingrove Theresa

SVP OF REGULATORY AFFAIRS

Officer
187,667 -98.2%
29.64
US$5,562,450 		187,667 -98.2% 29.64 US$5,562,450
2024-01-16 2024-01-16 PrS Proposed sale
1.2
Wingrove Theresa

Officer

Officer
187,667
29.64
US$5,561,602 		187,667 29.64 US$5,561,602
2023-12-27 2023-12-26 PlS Planned sale
1.1
Lentini Renee

VP & PRIN ACCTG OFFICER

Officer
6,548 -43.7%
29.74
US$194,738 		6,548 -43.7% 29.74 US$194,738
2023-12-26 2023-12-26 PrS Proposed sale
1.1
Lentini Renee

Officer

Officer
6,548
29.74
US$194,761 		6,548 29.74 US$194,761
2023-12-19 2023-12-15 PlS Planned sale
1.2
Wingrove Theresa

SVP OF REGULATORY AFFAIRS

Officer
117,445 -97.7%
29.40
US$3,452,883 		117,445 -97.7% 29.40 US$3,452,883
2023-12-15 2023-12-15 PrS Proposed sale
1.2
Wingrove Theresa

Officer

Officer
117,445
29.40
US$3,452,459 		117,445 29.40 US$3,452,459
2023-12-05 2023-11-30 PlS Planned sale
1.7
Coen Stacy Ann

SVP & CHIEF BUSINESS OFFICER

Officer
3,826 -10.4%
29.20
US$111,719 		3,826 -10.4% 29.20 US$111,719
2023-12-05 2023-11-30 PlS Planned sale
Peterson Kristine
Non-Executive Director
20,000 -100.0%
28.90
US$578,000 		20,000 -100.0% 28.90 US$578,000
2023-12-01 2023-11-30 PrS Proposed sale
1.7
Coen Stacy Ann

Officer

Officer
3,826
29.20
US$111,719 		3,826 29.20 US$111,719
2023-12-01 2023-11-30 PlS Planned sale
1.2
Wingrove Theresa

SVP OF REGULATORY AFFAIRS

Officer
164,424 -98.3%
28.95
US$4,760,075 		164,424 -98.3% 28.95 US$4,760,075
2023-11-30 2023-11-30 PrS Proposed sale
Peterson Kristine

Director

Non-Executive Director
20,000
28.90
US$578,048 		20,000 28.90 US$578,048
2023-11-30 2023-11-30 PrS Proposed sale
1.2
Wingrove Theresa

Officer

Officer
164,424
28.95
US$4,759,955 		164,424 28.95 US$4,759,955
2023-12-01 2023-11-29 PlS Planned sale
1.2
Wingrove Theresa

SVP OF REGULATORY AFFAIRS

Officer
6,792 -70.7%
16.66
US$113,155 		6,792 -70.7% 16.66 US$113,155
2023-11-29 2023-11-29 PrS Proposed sale
1.2
Wingrove Theresa

Officer

Officer
6,792
16.66
US$113,157 		6,792 16.66 US$113,157
2023-11-17 2023-11-17 PrS Proposed sale
1.7
Coen Stacy Ann

Officer

Officer
78,223
16.05
US$1,255,353 		78,223 16.05 US$1,255,353
2023-11-17 2023-11-17 PlS Planned sale
1.7
Coen Stacy Ann

SVP & CHIEF BUSINESS OFFICER

Officer
78,223 -67.9%
16.05
US$1,255,479 		78,223 -67.9% 16.05 US$1,255,479
2023-11-17 2023-11-16 PlS Planned sale
1.7
Coen Stacy Ann

SVP & CHIEF BUSINESS OFFICER

Officer
4,100 -10.0%
16.01
US$65,641 		4,100 -10.0% 16.01 US$65,641
2023-11-16 2023-11-16 PrS Proposed sale
1.7
Coen Stacy Ann

Officer

Officer
4,100
16.01
US$65,656 		4,100 16.01 US$65,656
2023-11-17 2023-11-15 PlS Planned sale
1.7
Coen Stacy Ann

SVP & CHIEF BUSINESS OFFICER

Officer
26,286 -41.6%
16.01
US$420,839 		26,286 -41.6% 16.01 US$420,839
2023-11-17 2023-11-15 PlS Planned sale
1.2
Wingrove Theresa

SVP OF REGULATORY AFFAIRS

Officer
166,725 -98.3%
15.85
US$2,642,591 		166,725 -98.3% 15.85 US$2,642,591
2023-11-15 2023-11-15 PrS Proposed sale
1.7
Coen Stacy Ann

Officer

Officer
26,286
16.01
US$420,849 		26,286 16.01 US$420,849
2023-11-15 2023-11-15 PrS Proposed sale
1.2
Wingrove Theresa

Officer

Officer
166,725
15.85
US$2,643,143 		166,725 15.85 US$2,643,143
2023-11-08 2023-11-07 PlS Planned sale
1.2
Wingrove Theresa

SVP OF REGULATORY AFFAIRS

Officer
19,517 -87.4%
16.66
US$325,153 		19,517 -87.4% 16.66 US$325,153
2023-11-07 2023-11-07 PrS Proposed sale
1.2
Wingrove Theresa

Officer

Officer
19,517
16.66
US$325,081 		19,517 16.66 US$325,081
2023-11-08 2023-11-06 S Sale
1.1
Lentini Renee

VP & PRIN ACCTG OFFICER

Officer
219,545 -100.0%
15.29
US$3,356,843 		219,545 -100.0% 15.29 US$3,356,843
2023-11-06 2023-11-06 PrS Proposed sale
1.1
Lentini Renee

Officer

Officer
219,545
15.29
US$3,356,796 		219,545 15.29 US$3,356,796
2023-11-02 2023-11-02 PrS Proposed sale
Berkenblit Anna

Officer

Officer
109,435
14.94
US$1,634,959 		109,435 14.94 US$1,634,959
2023-10-30 2023-10-30 PrS Proposed sale
1.6
Goldberg Mark Alan

Director

Non-Executive Director
10,000
15.08
US$150,762 		10,000 15.08 US$150,762
2023-10-18 2023-10-16 S Sale
1.2
Wingrove Theresa

SVP OF REGULATORY AFFAIRS

Officer
192,004 -98.6%
14.40
US$2,764,858 		192,004 -98.6% 14.40 US$2,764,858
2023-09-19 2023-09-19 PrS Proposed sale
Berkenblit Anna

Officer

Officer
547,888
16.00
US$8,766,208 		547,888 16.00 US$8,766,208
2023-09-18 2023-09-18 PrS Proposed sale
Berkenblit Anna

Officer

Officer
50,000
15.65
US$782,582 		50,000 15.65 US$782,582
2023-10-16 2023-09-15 PrS Proposed sale
1.2
Wingrove Theresa

Officer

Officer
192,004
14.40
US$2,764,597 		192,004 14.40 US$2,764,597
2023-09-19 2023-09-15 S Sale
1.2
Wingrove Theresa

SVP OF REGULATORY AFFAIRS

Officer
192,013 -98.6%
15.44
US$2,964,681 		192,013 -98.6% 15.44 US$2,964,681
2023-09-15 2023-09-15 PrS Proposed sale
1.2
Wingrove Theresa

Officer

Officer
192,013
15.44
US$2,965,492 		192,013 15.44 US$2,965,492
2023-09-13 2023-09-13 PrS Proposed sale
Peterson Kristine

Director

Non-Executive Director
10,000
16.08
US$160,754 		10,000 16.08 US$160,754
2023-09-13 2023-09-13 PrS Proposed sale
2.2
MCCLUSKI STEPHEN C

Director

Non-Executive Director
10,000
16.05
US$160,491 		10,000 16.05 US$160,491
2023-09-13 2023-09-13 PrS Proposed sale
Berkenblit Anna

Officer

Officer
100,000
16.09
US$1,609,337 		100,000 16.09 US$1,609,337
2023-09-11 2023-09-11 PrS Proposed sale
Berkenblit Anna

Officer

Officer
50,000
15.77
US$788,583 		50,000 15.77 US$788,583
2023-09-06 2023-09-06 PrS Proposed sale
Berkenblit Anna

Officer

Officer
50,000
15.67
US$783,739 		50,000 15.67 US$783,739
2023-09-01 2023-09-01 PrS Proposed sale
Berkenblit Anna

Officer

Officer
50,000
16.01
US$800,444 		50,000 16.01 US$800,444
2023-08-31 2023-08-31 PrS Proposed sale
Berkenblit Anna

Officer

Officer
50,000
15.76
US$788,011 		50,000 15.76 US$788,011
2023-08-30 2023-08-30 PrS Proposed sale
Berkenblit Anna

Officer

Officer
50,000
15.90
US$795,024 		50,000 15.90 US$795,024
2023-08-29 2023-08-29 PrS Proposed sale
Berkenblit Anna

Officer

Officer
50,000
15.95
US$797,613 		50,000 15.95 US$797,613
2023-08-28 2023-08-28 PrS Proposed sale
Berkenblit Anna

Officer

Officer
50,000
15.33
US$766,652 		50,000 15.33 US$766,652
2023-08-25 2023-08-25 PrS Proposed sale
Berkenblit Anna

Officer

Officer
50,000
15.97
US$798,359 		50,000 15.97 US$798,359
2023-08-24 2023-08-24 PrS Proposed sale
Berkenblit Anna

Officer

Officer
50,000
16.02
US$800,996 		50,000 16.02 US$800,996
2023-08-23 2023-08-23 PrS Proposed sale
Berkenblit Anna

Officer

Officer
50,000
16.50
US$825,025 		50,000 16.50 US$825,025
2023-08-22 2023-08-22 PrS Proposed sale
Berkenblit Anna

Officer

Officer
50,000
16.37
US$818,475 		50,000 16.37 US$818,475
2023-08-21 2023-08-21 PrS Proposed sale
Berkenblit Anna

Officer

Officer
50,000
15.75
US$787,642 		50,000 15.75 US$787,642
2023-08-18 2023-08-18 PrS Proposed sale
Berkenblit Anna

Officer

Officer
50,000
15.75
US$787,642 		50,000 15.75 US$787,642
2023-08-17 2023-08-17 PrS Proposed sale
Berkenblit Anna

Officer

Officer
50,000
15.81
US$790,348 		50,000 15.81 US$790,348
2023-08-16 2023-08-16 PrS Proposed sale
Berkenblit Anna

Officer

Officer
50,000
15.83
US$791,552 		50,000 15.83 US$791,552
2023-08-15 2023-08-15 PrS Proposed sale
Berkenblit Anna

Officer

Officer
50,000
15.54
US$777,117 		50,000 15.54 US$777,117
2023-08-14 2023-08-14 PrS Proposed sale
Berkenblit Anna

Officer

Officer
50,000
14.92
US$746,147 		50,000 14.92 US$746,147
2023-08-11 2023-08-09 S Sale
1.7
Coen Stacy Ann

SVP & CHIEF BUSINESS OFFICER

Officer
100,210 -90.1%
14.20
US$1,422,982 		100,210 -90.1% 14.20 US$1,422,982
2023-08-09 2023-08-09 PrS Proposed sale
1.7
Coen Stacy Ann

Officer

Officer
100,210
14.20
US$1,423,149 		100,210 14.20 US$1,423,149
2023-08-04 2023-08-04 PrS Proposed sale
1.7
Coen Stacy Ann

Officer

Officer
80,326
17.05
US$1,369,222 		80,326 17.05 US$1,369,222
2023-08-04 2023-08-04 PrS Proposed sale
2.5
Enyedy Mark J

Officer; Director

Executive Director
992,397
16.96
US$16,831,473 		992,397 16.96 US$16,831,473
2023-08-04 2023-08-04 S Sale
1.7
Coen Stacy Ann

SVP & CHIEF BUSINESS OFFICER

Officer
80,326 -88.0%
17.05
US$1,369,558 		80,326 -88.0% 17.05 US$1,369,558
2023-08-04 2023-08-04 S Sale
2.5
Enyedy Mark J

CHIEF EXECUTIVE OFFICER

Executive Director
992,397 -64.2%
16.96
US$16,831,053 		992,397 -64.2% 16.96 US$16,831,053
2023-08-04 2023-08-03 S Sale
2.5
Enyedy Mark J

CHIEF EXECUTIVE OFFICER

Executive Director
1,020,000 -69.8%
16.61
US$16,942,200 		1,020,000 -69.8% 16.61 US$16,942,200
2023-08-03 2023-08-03 PrS Proposed sale
2.5
Enyedy Mark J

Officer; Director

Executive Director
1,020,000
16.61
US$16,938,477 		1,020,000 16.61 US$16,938,477
2023-08-04 2023-08-02 S Sale
1.1
Lentini Renee

PRIN. FIN & ACCTG. OFF.

Officer
148,277 -86.7%
17.55
US$2,602,261 		148,277 -86.7% 17.55 US$2,602,261
2023-08-04 2023-08-02 S Sale
1.7
Coen Stacy Ann

SVP & CHIEF BUSINESS OFFICER

Officer
4,255 -28.0%
18.12
US$77,101 		4,255 -28.0% 18.12 US$77,101
2023-08-04 2023-08-02 S Sale
2.5
Enyedy Mark J

CHIEF EXECUTIVE OFFICER

Executive Director
8,636 -1.9%
18.15
US$156,743 		8,636 -1.9% 18.15 US$156,743
2023-08-04 2023-08-02 S Sale
2.5
Enyedy Mark J

CHIEF EXECUTIVE OFFICER

Executive Director
986,521 -68.7%
17.45
US$17,214,791 		986,521 -68.7% 17.45 US$17,214,791
2023-08-02 2023-08-02 PrS Proposed sale
1.1
Lentini Renee

Officer

Officer
148,277
17.55
US$2,602,499 		148,277 17.55 US$2,602,499
Explore more

More insider trading research around ImmunoGen Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America